Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000542631 | SCV000629312 | likely benign | Retinoblastoma | 2024-01-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001015826 | SCV001176704 | likely benign | Hereditary cancer-predisposing syndrome | 2018-10-10 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Color Diagnostics, |
RCV000542631 | SCV004357208 | likely benign | Retinoblastoma | 2022-05-04 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000542631 | SCV004844751 | likely benign | Retinoblastoma | 2023-12-13 | criteria provided, single submitter | clinical testing |